IGFLOW-SF 500 is a combination medication used to manage asthma and chronic obstructive pulmonary disease (COPD). It contains two active ingredients: fluticasone propionate and salmeterol. Fluticasone is a corticosteroid that reduces inflammation in the airways, while salmeterol is a long-acting beta agonist (LABA) that helps to relax the muscles around the airways, making breathing easier.

IGFLOW-SF 500 is typically prescribed for patients who require higher doses of inhaled corticosteroids and long-acting beta agonists to control their symptoms. It is available as an DPI and should be used regularly as directed by a healthcare professional to effectively manage asthma or COPD symptoms and reduce the risk of exacerbations. It's important to rinse the mouth with water after using IGFLOW-SF to minimize the risk of developing oral thrush. As with any medication, it's essential to follow the prescribing healthcare professional's instructions and be aware of any potential side effects.